Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Opioids Drugs market report explains the definition, types, applications, major countries, and major players of the Opioids Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
INSYS
Endo
J&J
Pfizer
Mallinckrodt
Hikma
Vistapharm
Depomed
Purdue Pharma
Mylan
Egalet
Pernix
Teva
By Type:
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other
By End-User:
Pain Relief
Anesthesia
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Opioids Drugs Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Opioids Drugs Outlook to 2028- Original Forecasts
-
2.2 Opioids Drugs Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Opioids Drugs Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Opioids Drugs Market- Recent Developments
-
6.1 Opioids Drugs Market News and Developments
-
6.2 Opioids Drugs Market Deals Landscape
7 Opioids Drugs Raw Materials and Cost Structure Analysis
-
7.1 Opioids Drugs Key Raw Materials
-
7.2 Opioids Drugs Price Trend of Key Raw Materials
-
7.3 Opioids Drugs Key Suppliers of Raw Materials
-
7.4 Opioids Drugs Market Concentration Rate of Raw Materials
-
7.5 Opioids Drugs Cost Structure Analysis
-
7.5.1 Opioids Drugs Raw Materials Analysis
-
7.5.2 Opioids Drugs Labor Cost Analysis
-
7.5.3 Opioids Drugs Manufacturing Expenses Analysis
8 Global Opioids Drugs Import and Export Analysis (Top 10 Countries)
-
8.1 Global Opioids Drugs Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Opioids Drugs Export by Region (Top 10 Countries) (2017-2028)
9 Global Opioids Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Opioids Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oxycodone Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Hydromorphone Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Codeine Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Fentanyl Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Opioids Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Pain Relief Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Anesthesia Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Opioids Drugs Market Analysis and Outlook till 2022
-
10.1 Global Opioids Drugs Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Opioids Drugs Consumption (2017-2022)
-
10.2.2 Canada Opioids Drugs Consumption (2017-2022)
-
10.2.3 Mexico Opioids Drugs Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Opioids Drugs Consumption (2017-2022)
-
10.3.2 UK Opioids Drugs Consumption (2017-2022)
-
10.3.3 Spain Opioids Drugs Consumption (2017-2022)
-
10.3.4 Belgium Opioids Drugs Consumption (2017-2022)
-
10.3.5 France Opioids Drugs Consumption (2017-2022)
-
10.3.6 Italy Opioids Drugs Consumption (2017-2022)
-
10.3.7 Denmark Opioids Drugs Consumption (2017-2022)
-
10.3.8 Finland Opioids Drugs Consumption (2017-2022)
-
10.3.9 Norway Opioids Drugs Consumption (2017-2022)
-
10.3.10 Sweden Opioids Drugs Consumption (2017-2022)
-
10.3.11 Poland Opioids Drugs Consumption (2017-2022)
-
10.3.12 Russia Opioids Drugs Consumption (2017-2022)
-
10.3.13 Turkey Opioids Drugs Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Opioids Drugs Consumption (2017-2022)
-
10.4.2 Japan Opioids Drugs Consumption (2017-2022)
-
10.4.3 India Opioids Drugs Consumption (2017-2022)
-
10.4.4 South Korea Opioids Drugs Consumption (2017-2022)
-
10.4.5 Pakistan Opioids Drugs Consumption (2017-2022)
-
10.4.6 Bangladesh Opioids Drugs Consumption (2017-2022)
-
10.4.7 Indonesia Opioids Drugs Consumption (2017-2022)
-
10.4.8 Thailand Opioids Drugs Consumption (2017-2022)
-
10.4.9 Singapore Opioids Drugs Consumption (2017-2022)
-
10.4.10 Malaysia Opioids Drugs Consumption (2017-2022)
-
10.4.11 Philippines Opioids Drugs Consumption (2017-2022)
-
10.4.12 Vietnam Opioids Drugs Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Opioids Drugs Consumption (2017-2022)
-
10.5.2 Colombia Opioids Drugs Consumption (2017-2022)
-
10.5.3 Chile Opioids Drugs Consumption (2017-2022)
-
10.5.4 Argentina Opioids Drugs Consumption (2017-2022)
-
10.5.5 Venezuela Opioids Drugs Consumption (2017-2022)
-
10.5.6 Peru Opioids Drugs Consumption (2017-2022)
-
10.5.7 Puerto Rico Opioids Drugs Consumption (2017-2022)
-
10.5.8 Ecuador Opioids Drugs Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Opioids Drugs Consumption (2017-2022)
-
10.6.2 Kuwait Opioids Drugs Consumption (2017-2022)
-
10.6.3 Oman Opioids Drugs Consumption (2017-2022)
-
10.6.4 Qatar Opioids Drugs Consumption (2017-2022)
-
10.6.5 Saudi Arabia Opioids Drugs Consumption (2017-2022)
-
10.6.6 United Arab Emirates Opioids Drugs Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Opioids Drugs Consumption (2017-2022)
-
10.7.2 South Africa Opioids Drugs Consumption (2017-2022)
-
10.7.3 Egypt Opioids Drugs Consumption (2017-2022)
-
10.7.4 Algeria Opioids Drugs Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Opioids Drugs Consumption (2017-2022)
-
10.8.2 New Zealand Opioids Drugs Consumption (2017-2022)
11 Global Opioids Drugs Competitive Analysis
-
11.1 INSYS
-
11.1.1 INSYS Company Details
-
11.1.2 INSYS Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 INSYS Opioids Drugs Main Business and Markets Served
-
11.1.4 INSYS Opioids Drugs Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Endo
-
11.2.1 Endo Company Details
-
11.2.2 Endo Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Endo Opioids Drugs Main Business and Markets Served
-
11.2.4 Endo Opioids Drugs Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 J&J
-
11.3.1 J&J Company Details
-
11.3.2 J&J Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 J&J Opioids Drugs Main Business and Markets Served
-
11.3.4 J&J Opioids Drugs Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Pfizer
-
11.4.1 Pfizer Company Details
-
11.4.2 Pfizer Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Pfizer Opioids Drugs Main Business and Markets Served
-
11.4.4 Pfizer Opioids Drugs Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Mallinckrodt
-
11.5.1 Mallinckrodt Company Details
-
11.5.2 Mallinckrodt Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Mallinckrodt Opioids Drugs Main Business and Markets Served
-
11.5.4 Mallinckrodt Opioids Drugs Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Hikma
-
11.6.1 Hikma Company Details
-
11.6.2 Hikma Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Hikma Opioids Drugs Main Business and Markets Served
-
11.6.4 Hikma Opioids Drugs Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Vistapharm
-
11.7.1 Vistapharm Company Details
-
11.7.2 Vistapharm Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Vistapharm Opioids Drugs Main Business and Markets Served
-
11.7.4 Vistapharm Opioids Drugs Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Depomed
-
11.8.1 Depomed Company Details
-
11.8.2 Depomed Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Depomed Opioids Drugs Main Business and Markets Served
-
11.8.4 Depomed Opioids Drugs Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Purdue Pharma
-
11.9.1 Purdue Pharma Company Details
-
11.9.2 Purdue Pharma Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Purdue Pharma Opioids Drugs Main Business and Markets Served
-
11.9.4 Purdue Pharma Opioids Drugs Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Mylan
-
11.10.1 Mylan Company Details
-
11.10.2 Mylan Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Mylan Opioids Drugs Main Business and Markets Served
-
11.10.4 Mylan Opioids Drugs Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Egalet
-
11.11.1 Egalet Company Details
-
11.11.2 Egalet Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Egalet Opioids Drugs Main Business and Markets Served
-
11.11.4 Egalet Opioids Drugs Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Pernix
-
11.12.1 Pernix Company Details
-
11.12.2 Pernix Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Pernix Opioids Drugs Main Business and Markets Served
-
11.12.4 Pernix Opioids Drugs Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Teva
-
11.13.1 Teva Company Details
-
11.13.2 Teva Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Teva Opioids Drugs Main Business and Markets Served
-
11.13.4 Teva Opioids Drugs Product Portfolio
-
11.13.5 Recent Research and Development Strategies
12 Global Opioids Drugs Market Outlook by Types and Applications to 2028
-
12.1 Global Opioids Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Oxycodone Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Hydromorphone Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Codeine Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Fentanyl Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Opioids Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Pain Relief Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Anesthesia Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Opioids Drugs Market Analysis and Outlook to 2028
-
13.1 Global Opioids Drugs Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Opioids Drugs Consumption Forecast (2022-2028)
-
13.2.2 Canada Opioids Drugs Consumption Forecast (2022-2028)
-
13.2.3 Mexico Opioids Drugs Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Opioids Drugs Consumption Forecast (2022-2028)
-
13.3.2 UK Opioids Drugs Consumption Forecast (2022-2028)
-
13.3.3 Spain Opioids Drugs Consumption Forecast (2022-2028)
-
13.3.4 Belgium Opioids Drugs Consumption Forecast (2022-2028)
-
13.3.5 France Opioids Drugs Consumption Forecast (2022-2028)
-
13.3.6 Italy Opioids Drugs Consumption Forecast (2022-2028)
-
13.3.7 Denmark Opioids Drugs Consumption Forecast (2022-2028)
-
13.3.8 Finland Opioids Drugs Consumption Forecast (2022-2028)
-
13.3.9 Norway Opioids Drugs Consumption Forecast (2022-2028)
-
13.3.10 Sweden Opioids Drugs Consumption Forecast (2022-2028)
-
13.3.11 Poland Opioids Drugs Consumption Forecast (2022-2028)
-
13.3.12 Russia Opioids Drugs Consumption Forecast (2022-2028)
-
13.3.13 Turkey Opioids Drugs Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Opioids Drugs Consumption Forecast (2022-2028)
-
13.4.2 Japan Opioids Drugs Consumption Forecast (2022-2028)
-
13.4.3 India Opioids Drugs Consumption Forecast (2022-2028)
-
13.4.4 South Korea Opioids Drugs Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Opioids Drugs Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Opioids Drugs Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Opioids Drugs Consumption Forecast (2022-2028)
-
13.4.8 Thailand Opioids Drugs Consumption Forecast (2022-2028)
-
13.4.9 Singapore Opioids Drugs Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Opioids Drugs Consumption Forecast (2022-2028)
-
13.4.11 Philippines Opioids Drugs Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Opioids Drugs Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Opioids Drugs Consumption Forecast (2022-2028)
-
13.5.2 Colombia Opioids Drugs Consumption Forecast (2022-2028)
-
13.5.3 Chile Opioids Drugs Consumption Forecast (2022-2028)
-
13.5.4 Argentina Opioids Drugs Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Opioids Drugs Consumption Forecast (2022-2028)
-
13.5.6 Peru Opioids Drugs Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Opioids Drugs Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Opioids Drugs Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Opioids Drugs Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Opioids Drugs Consumption Forecast (2022-2028)
-
13.6.3 Oman Opioids Drugs Consumption Forecast (2022-2028)
-
13.6.4 Qatar Opioids Drugs Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Opioids Drugs Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Opioids Drugs Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Opioids Drugs Consumption Forecast (2022-2028)
-
13.7.2 South Africa Opioids Drugs Consumption Forecast (2022-2028)
-
13.7.3 Egypt Opioids Drugs Consumption Forecast (2022-2028)
-
13.7.4 Algeria Opioids Drugs Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Opioids Drugs Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Opioids Drugs Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Opioids Drugs
-
Figure of Opioids Drugs Picture
-
Table Global Opioids Drugs Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Opioids Drugs Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Oxycodone Consumption and Growth Rate (2017-2022)
-
Figure Global Hydromorphone Consumption and Growth Rate (2017-2022)
-
Figure Global Codeine Consumption and Growth Rate (2017-2022)
-
Figure Global Fentanyl Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Pain Relief Consumption and Growth Rate (2017-2022)
-
Figure Global Anesthesia Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Opioids Drugs Consumption by Country (2017-2022)
-
Table North America Opioids Drugs Consumption by Country (2017-2022)
-
Figure United States Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Canada Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Mexico Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Opioids Drugs Consumption by Country (2017-2022)
-
Figure Germany Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure UK Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Spain Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Belgium Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure France Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Italy Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Denmark Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Finland Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Norway Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Sweden Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Poland Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Russia Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Turkey Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Table APAC Opioids Drugs Consumption by Country (2017-2022)
-
Figure China Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Thailand Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Singapore Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Philippines Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Table South America Opioids Drugs Consumption by Country (2017-2022)
-
Figure Brazil Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Colombia Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Chile Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Argentina Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Peru Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Table GCC Opioids Drugs Consumption by Country (2017-2022)
-
Figure Bahrain Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Oman Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Qatar Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Table Africa Opioids Drugs Consumption by Country (2017-2022)
-
Figure Nigeria Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Africa Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Egypt Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure Algeria Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Table Oceania Opioids Drugs Consumption by Country (2017-2022)
-
Figure Australia Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Opioids Drugs Consumption and Growth Rate (2017-2022)
-
Table INSYS Company Details
-
Table INSYS Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table INSYS Opioids Drugs Main Business and Markets Served
-
Table INSYS Opioids Drugs Product Portfolio
-
Table Endo Company Details
-
Table Endo Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Endo Opioids Drugs Main Business and Markets Served
-
Table Endo Opioids Drugs Product Portfolio
-
Table J&J Company Details
-
Table J&J Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table J&J Opioids Drugs Main Business and Markets Served
-
Table J&J Opioids Drugs Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Opioids Drugs Main Business and Markets Served
-
Table Pfizer Opioids Drugs Product Portfolio
-
Table Mallinckrodt Company Details
-
Table Mallinckrodt Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mallinckrodt Opioids Drugs Main Business and Markets Served
-
Table Mallinckrodt Opioids Drugs Product Portfolio
-
Table Hikma Company Details
-
Table Hikma Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hikma Opioids Drugs Main Business and Markets Served
-
Table Hikma Opioids Drugs Product Portfolio
-
Table Vistapharm Company Details
-
Table Vistapharm Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vistapharm Opioids Drugs Main Business and Markets Served
-
Table Vistapharm Opioids Drugs Product Portfolio
-
Table Depomed Company Details
-
Table Depomed Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Depomed Opioids Drugs Main Business and Markets Served
-
Table Depomed Opioids Drugs Product Portfolio
-
Table Purdue Pharma Company Details
-
Table Purdue Pharma Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Purdue Pharma Opioids Drugs Main Business and Markets Served
-
Table Purdue Pharma Opioids Drugs Product Portfolio
-
Table Mylan Company Details
-
Table Mylan Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Opioids Drugs Main Business and Markets Served
-
Table Mylan Opioids Drugs Product Portfolio
-
Table Egalet Company Details
-
Table Egalet Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Egalet Opioids Drugs Main Business and Markets Served
-
Table Egalet Opioids Drugs Product Portfolio
-
Table Pernix Company Details
-
Table Pernix Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pernix Opioids Drugs Main Business and Markets Served
-
Table Pernix Opioids Drugs Product Portfolio
-
Table Teva Company Details
-
Table Teva Opioids Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Opioids Drugs Main Business and Markets Served
-
Table Teva Opioids Drugs Product Portfolio
-
Figure Global Oxycodone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hydromorphone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Codeine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fentanyl Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pain Relief Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anesthesia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Opioids Drugs Consumption Forecast by Country (2022-2028)
-
Table North America Opioids Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Opioids Drugs Consumption Forecast by Country (2022-2028)
-
Figure Germany Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Opioids Drugs Consumption Forecast by Country (2022-2028)
-
Figure China Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Opioids Drugs Consumption Forecast by Country (2022-2028)
-
Figure Brazil Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Opioids Drugs Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Opioids Drugs Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Opioids Drugs Consumption Forecast by Country (2022-2028)
-
Figure Australia Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Opioids Drugs Consumption Forecast and Growth Rate (2022-2028)
-
